november AG

euro adhoc: november AG
other
Creditor's meetings approve insolvency plans Creditor’s meetings of november AG i.I., identif GmbH i.I. and directif GmbH i.I. approve the insolvency plans presented to them as essential requirement for the financial res

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- 12.03.2007 Erlangen, 12 March 2007. The creditor's meeting of november AG i.l. (ISIN DE0006762909), a biotech development- and investment-holding located in Erlangen, Germany, has - in it's second session - approved the insolvency plan presented to it. In subsequent separate meetings, the creditors of identif GmbH i.I. and directif GmbH i.I. approved the insolvency plan as well. The approvals are essential requirements for a successful financial restructuring. November AG i.l. and Biomed-Group, Freiburg, Germany, as well as Dr. Claus Müller intend to take further steps for a successful financial restructuring .The success of the financial restructuring depends on the approvals of the corporate bodies of november AG i.I. as well as on other authorisations. end of announcement euro adhoc 12.03.2007 16:39:14 -------------------------------------------------------------------------------- ots Originaltext: november AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Marcus Weichert Leitung PR/IR Telefon: +49(0)9131 75088 868 E-Mail: weichert@november.de Branche: Biotechnology ISIN: DE0006762909 WKN: 676290 Index: CDAX, Technologie All Share, Prime All Share Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime standard Börse Berlin-Bremen / free trade Baden-Württembergische Wertpapierbörse / free trade Börse Düsseldorf / free trade Niedersächsische Börse zu Hannover / free trade Bayerische Börse / free trade

Das könnte Sie auch interessieren: